Menu
Intermediates
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
| S.No | Category | Product Name | CAS No. |
|---|---|---|---|
| 1.1 | Carvedilol Intermediate | 1,3-Cyclohexanedione | 504-02-9 |
| 1.2 | Carvedilol Intermediate | 1,2,3,9-tetrahydro-4H-carbazol-4-one | 15128-52-6 |
| 1.3 | Carvedilol Intermediate | 4-Hydroxycarbazole | 52602-39-8 |
| 1.4 | Carvedilol Intermediate | 4-(2,3-Epoxypropoxy)carbazole | 51997-51-4 |
| 1.5 | Carvedilol Intermediate | 2-(2-Methoxyphenoxy)ethylamine | 1836-62-0 |
| 1.6 | Carvedilol Intermediate | 2-(2-Methoxyphenoxy)ethylamine HCL | 64464-07-9 |
| 1.7 | Carvedilol Intermediate | N-(2-(2-Methoxyphenoxy)ethyl)benzylamine | 3246-03-5 |
| 1.8 | Carvedilol Intermediate | N-(2-(2-Methoxyphenoxy)ethyl)benzylamine HCL | 120606-08-8 |
| 1.9 | Carvedilol Intermediate | 2-[2-(2-methoxyphenoxy)ethyl]-1H-isoindole-1,3(2H)-dione | 26646-63-9 |
| 2.1 | Citalopram / Escitalopram Intermediate | 4-[(4’-Dimethyl amino)-1-(4”-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy methyl) benzonitrile | 103146-25-4 |
| 2.2 | Citalopram / Escitalopram Intermediate | 4-[(4’-Dimethyl amino)-1-(4”-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy methyl) benzonitrile HBr | 103146-26-5 |
| 2.3 | Citalopram / Escitalopram Intermediate | 4-[(4’-Dimethyl amino)-1-(4”-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy methyl) benzonitrile HCL | 717133-25-0 |
| 2.4 | Citalopram / Escitalopram Intermediate | 4-[(4’-Dimethyl amino)-1-(4”-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy methyl) benzonitrile Oxalate | 717133-32-9 |
| 2.5 | Citalopram / Escitalopram Intermediate | 4-[(4-(Dimethyl amino)-1-(4”-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy methyl) benzonitrile hemi DPPTA salt | 128173-53-5 |
| 2.6 | Citalopram / Escitalopram Intermediate | 1-[3-(Dimethylamino)-propyl]-1-(4-fluoro phenyl)-5-phthalan carbonitrile HCl | 85118-27-0 |
| 2.7 | Citalopram / Escitalopram Intermediate | 1-(4’-Fluoro phenyl)-1,3-dihydro iso benzofuran-5-carbonitrile | 64169-67-1 |
| 2.8 | Citalopram / Escitalopram Intermediate | 1-(4-bromo-2-(hydroxymethyl)phenyl)-4-(dimethylamino)-1-(4-fluorophenyl) butan-1-ol oxalate | - |
| 2.9 | Citalopram / Escitalopram Intermediate | 3-N,N’-(dimethylamino)propyl chloride Hydrochloride | 5407-04-51 |
2.10 | Citalopram / Escitalopram Intermediate | 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)1,3-dihydroisobenzofuran-5-carbonitrile | 59729-33-8 |
| 2.11 | Citalopram / Escitalopram Intermediate | 5-Bromo-1-(3-dimethyl amino propyl) –1-(4’fluoro phenyl)-1,3-dihydro isobenzofuran oxalate | - |
| 3.1 | Duloxetine Intermediate | RS-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamine | 13636-02-7 |
| 3.2 | Duloxetine Intermediate | S(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamine | 132335-44-5 |
| 3.3 | Duloxetine Intermediate | S-(+)-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-thienyl)-1-propanamine oxalate | 132335-47-8 |
| 3.4 | Duloxetine Intermediate | RS-N,N- Dimethyl-3-(1-Naphthalenyloxy)-3-(2-thienyl)-1-propanamine oxalate | 116817-12-0 |
| 3.5 | Duloxetine Intermediate | (N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine fumarate | - |
| 3.6 | Duloxetine Intermediate | N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine Oxalate (Racemic Duloxetine Oxalate) | - |
| 4.1 | Ondansetron Intermediate | 1,2,3,9-tetrahydro-4H-carbazol-4-one | 15128-52-6 |
| 4.2 | Ondansetron Intermediate | 9-Methyl-1,2,3,9-tetra hydro 4H carbazol-4-one | 27387-31-1 |
| 4.3 | Ondansetron Intermediate | 3-[(NN-Dimethyl amino) methyl]-9-methyl-1,2,3,9-tetra hydro 4H-carbazol-4-one hydrochloride | 119812-29-2 |
| 5.1 | Rivastigmine Intermediate | ?-(meta hydroxy phenyl) ethyldimethyl amine | 105601-04-5 |
| 5.2 | Rivastigmine Intermediate | ?-(meta hydroxy phenyl) ethyldimethyl amine HCL | 5441-61-2 |
| 5.3 | Rivastigmine Intermediate | S (+)-? meta hydroxy phenyl)ethyl dimethyl amine | 139306-10-8 |
| 6.1 | Rotigotine Intermediate | (S)-1,2,3,4-tetrahydro-5-methoxynaphthalen-2-amine Mandelate | 439133-67-2 |
| 6.2 | Rotigotine Intermediate | 2-(Thiophen-2-yl)ethyl 4-methylbenzenesulfonate | 40412-06-4 |
| 6.3 | Rotigotine Intermediate | (S)-1,2,3,4-tetrahydro-5-methoxy-N-(2-(thiophen-2-yl)ethyl)naphthalen-2-amine hydrochloride | - |
| 7.1 | Ranolazine Intermediate | N-(2,6-dimethylphenyl)-2-(piperazin-1-yl)acetamide | 5294-61-1 |
| 7.2 | Ranolazine Intermediate | 2-((2-methoxyphenoxy)methyl)oxirane | 2210-74-4 |
| 8.1 | Raloxifene Intermediate | 4-(2-(PIPERIDIN-1-YL)ETHOXY)BENZOIC ACID HYDROCHLORIDE | 84449-80-9 |
| 8.2 | Raloxifene Intermediate | 6-Methylsulfonyloxy-2-[(4-methyl sulfonyloxy) phenyl] benzothiophene | 84449-65-0 |
| 9.1 | Silodosin Intermediate | 2-(2-(2,2,2-trifluoroethoxy)-phenoxy)-ethyl methanesulfonate---- | 160969-03-9 |
| 9.2 | Silodosin Intermediate | 5-[(2R)-2-Aminopropyl]-1-[3-(Benzoyloxy)propyl]-2,3-dihydro -1H-indole-7-carbonitrile(2R,3R)-2,3-dihydroxy butanedioate | 239463-85-5 |
| 9.3 | Silodosin Intermediate | 1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carbonitrile | 885340-11-4 |
| 9.4 | Silodosin Intermediate | 1H-Indole-7-carbonitrile, 2,3-dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)ph enoxy]ethyl]amino]propyl] | 885340-13-6 |
| 10.1 | Sitagliptin intermediate | 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | 762240-92-6 |
| 10.2 | Sitagliptin intermediate | 1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione /(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo [4,3-a]pyrazine-7(8H)-yl]-1-[2,4,5-trifluorophenyl)butan-2-one | 764667-65-4 |
| 11.1 | Tolterodine Tartrate Intermediate | 3-(2-Methoxy-5-methylphenyl)-3-phenylpropan-1-ol | 124937-73-1 |
| 11.2 | Tolterodine Tartrate Intermediate | 3,4-Dihydro-6-methyl-4-phenylchromen-2-one | 40546-94-9 |
| 11.3 | Tolterodine Tartrate Intermediate | 2-(3-(diisopropylamino)-1-phenylpropyl)-4-methylphenol (Racemic Tolterodine) | 124936-74-9 |
| 12.1 | Varenicline Intermediate | 1,2,3,4-Tetrahydro-1,4-methano-naphthalene-2,3-diol | 70187-32-5 |
| 12.2 | Varenicline Intermediate | 2,3,4,5-Tetrahydro-1H-1,5-methanobenzo[d]azepine hydrochloride | 230615-52-8 |
| 13.1 | Ziprasidone Intermediate | 3-(1-Piperazinyl)-1,2-Benzisothiazole HCL | 87691-88-1 |
| 13.2 | Ziprasidone Intermediate | 3-(Piperazin-1-yl)Benzo[d]isothiazole | 87691-87-0 |
| 13.3 | Ziprasidone Intermediate | 6-Chloroindolin-2-one | 56341-37-8 |
| 13.4 | Ziprasidone Intermediate | 6-Chloro-5-(2-chloroethyl)indolin-2-one | 118289-55-7 |
| 14.1 | Bilastine Intermediate | 2-Ethoxyethyl-4-methylbenzenesulfonate | 17178-11-9 |
| 14.2 | Bilastine Intermediate | 2-Piperidin-4-yl-1H-benzoimidazole | 38385-95-4 |
| 15.1 | Carteolol Intermediate | 3,4-dihydro-5-hydroxyquinolin-2(1H)-one | 30389-33-4 |
| 15.2 | Carteolol Intermediate | 5-((oxiran-2-yl)methoxy)-3,4-dihydroquinolin-2(1H)-one | 51781-14-7 |
| 16.1 | Cilostazol intermediate | 6-Hydroxy-3,4-dihydro-2(1H)-quinolinone | 54197-66-9 |
| 17.1 | Dapoxetine Intermediate | 3-Chloro-1-phenylpropan-1-ol | 18776-12-0 |
| 17.2 | Dapoxetine Intermediate | Racemic Dapoxetine Oxalate | - |
| 17.3 | Dapoxetine Intermediate | Racemic Dapoxetine Hydrochloride | 1071929-03-7 |
| 17.4 | Dapoxetine Intermediate | Dapoxetine Base | 119356-77-3 |
| 18.1 | Darifenacin intermediate | 2,2-Diphenyl-2-((R)-pyrrolidin-3-yl)acetonitrile hydrobromide | 194602-27-2 |
| 18.2 | Darifenacin intermediate | 3-(S)-(+)-(1-carbamoyl-1,1-diphenylmethyl) pyrrolidine - L-(+)-tartrate | 134002-26-9 |
| 18.3 | Darifenacin intermediate | 5-(2-chloroethyl)-2,3-dihydrobenzofuran | 943034-50-2 |
| 18.4 | Darifenacin intermediate | 5-(2-bromoethyl)-2,3-dihydrobenzofuran | 127264-14-6 |
| 19.1 | Lacosamide Intermediate | Boc-D-Serine | 6368-20-3 |
| 19.2 | Lacosamide Intermediate | Boc-O-Methyl-D-serine | 86123-95-7 |
| 19.3 | Lacosamide Intermediate | (R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate | 880468-89-3 |
| 19.4 | Lacosamide Intermediate | (R)-2-amino-N-benzyl-3-methoxypropanamide | 196601-69-1 |
| 19.5 | Lacosamide Intermediate | N-Cbz-D-Serine | 6081-61-4 |
| 19.6 | Lacosamide Intermediate | (R)-N-benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide | 219835-31-1 |
| 20.1 | Lidocaine intermediate | 2-chloro-N-(2,6-dimethylphenyl)acetamide | 1131-01-7 |
| 21.1 | Nebivolol Intermediate | (RS)- 6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid | - |
| 21.2 | Nebivolol Intermediate | (S)- 6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid | 129101-36-6 |
| 21.3 | Nebivolol Intermediate | R-6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid | 129101-37-7 |
| 21.4 | Nebivolol Intermediate | (6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)(piperidin-1-yl)methanone | 878208-57-2 |
| 21.5 | Nebivolol Intermediate | 6-Fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran (Mixture of Two Diastereomers) | 99199-90-3 |
| 21.6 | Nebivolol Intermediate | 2-(benzylamino)-1-(6-fluorochroman-2-yl)ethanol | 99199-91-4 |
| 21.7 | Nebivolol Intermediate | N-Benzyl Nebivolol Hydrochloride | - |
| 22.1 | Racecadotril Intermediate | Diethyl-2-benzylmalonate | 607-81-8 |
| 22.2 | Racecadotril Intermediate | 2-Benzylacrylic acid | 5669-19-2 |
| 22.3 | Racecadotril Intermediate | Glycine benzyl ester P-toluene sulfonic acid | 1738-76-7 |
| 22.4 | Racecadotril Intermediate | Dimethyl-2-benzylmalonate | 6626-84-2 |
| 23.1 | Repaglinide Intermediate | (S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine N-Acetyl-L-glutamate | 219921-94-5 |
| 23.2 | Repaglinide Intermediate | (S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine | 147769-93-5 |
| 23.3 | Repaglinide Intermediate | (S)-Repaglinide Ethyl Ester | 147770-06-7 |
| 24.1 | Tartaric Acid Derivative | (+)-Di-p-toluoyl-D-tartaric Acid | 32634-68-7 |
| 24.2 | Tartaric Acid Derivative | (-)-Di-p-toluoyl-L-tartaric Acid | 32634-66-5 |
| 24.3 | Tartaric Acid Derivative | (+)-Dibenzoyl-D-tartaric Acid | 100632-52-8 |
| 24.4 | Tartaric Acid Derivative | (-)-Dibenzoyl-L-tartaric Acid | 2743-38-6 |
| 24.5 | Tartaric Acid Derivative | Diethyl- D –Tartrate | 13811-71-7 |
| 25.1 | Sofosbuvir intermediate | L-Alanine Isopropyl ester hydrochloride | 39825-33-7 |
| 26.1 | Valsartan intermediate | L-Valine methyl ester hydrochloride | 6306-52-1 |
| 26.2 | Valsartan intermediate | N-[(2'-Cyanobiphenyl-4-methyl)-(L)-Valine methyl ester Hydrochloride | 482577-59-3 |
| 26.3 | Valsartan intermediate | L-Valine benzyl ester hydrochloride | 2462–34-2 |
| 26.4 | Valsartan intermediate | L-Valine benzyl ester p-toluene sulfonate | 16652-76-9 |
| 27.1 | Vildagliptin intermediate | (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile | 207557-35-5 |
| 28.1 | D- Serine Derivative | D Serine Methyl Ester HCL | 5874-57-7 |
| 28.2 | D- Serine Derivative | N-BOC-D-Serine Methyl Ester | 95715-85-8 |
| 29.1 | L Valine Derivative | L Valine Methyl Ester HCL | 6306-52-1 |
| 29.2 | L Valine Derivative | N-CbZ-L-Valine | 1149-26-4 |
| 29.3 | L Valine Derivative | L Valinamide Hcl | 3014-80-0 |
| 29.4 | L Valine Derivative | N BOC L Valine | 13734-41-3 |
| 30.1 | L Proline Derivative | L Prolinamide | 7531-52-4 |
| 30.2 | L Proline Derivative | N-BOC-L-Proline | 15761-39-4 |
| 30.3 | L Proline Derivative | N-BOC-Prolinamide/ D-N-BOC-Prolinamide | 70138-72-6 |
| 30.4 | L Proline Derivative | L-Proline Methyl Ester HCL | 2133-40-6 |
| 30.5 | L Proline Derivative | N-CBZ-L-Proline | 1148-11-4 |
| 31.1 | L Alanine Derivative | L Analine Methyl Ester HCL | 2491-20-5 |
| 31.2 | L Alanine Derivative | (S)-3- Chloroalanine Methyl Ester HCL | 112346-82-4 |
| 32.01 | Other products | 1.9 - Decadiene | 1647-16-1 |
| 32.02 | Other products | 2 methyl 1,3 cyclohexane dione | 1193-55-1 |
| 32.03 | Other products | Flufenamic acid | 530-78-9 |
| 32.04 | Other products | N-Methyl-1-Naphthyl Methyl Amine HCL | 65473-13-4 |
| 32.05 | Other products | O-Benzyl-L-threonine benzyl ester oxalate | 15260-11-4 |
| 32.06 | Other products | Ortho Phthalaldehyde | 643-79-8 |
| 32.07 | Other products | (2-Chlorophenyl) acetaldehyde | 4251-63-2 |
| 32.08 | Other products | (S)-(-)-2-(3,4- Dimethoxybenzyl)-2-hydrazinyl Propionic Acid | - |
| 32.09 | Other products | [3-(Dimethylamino)propyl] triphenyl phosphonium bromide Hydrobromide | 27710-82-3 |
32.10 | Other products | 1,2-Cyclohexanedione | 765-87-7 |
| 32.11 | Other products | 2-Chlorothioxanthone | 86-39-5 |
| 32.12 | Other products | 3-(N, N-diisopropylamino)-1-phenylpropan-1-ol | 906532-26-1 |
| 32.13 | Other products | 3,6 Dibromo N Phenyl Carbazole | 57103-20-5 |
| 32.14 | Other products | 3-fluoro-4-(hydroxymethyl) benzonitrile (FHB-2) | 219873-06-0 |
| 32.15 | Other products | 4-[(2-Carboxyphenyl) methoxy] benzene acetic acid | 55453-89-9 |
| 32.16 | Other products | 4-acetyl-piperidine-1-carboxylic acid tert-butyl ester | 206989-61-9 |
| 32.17 | Other products | 5-Methoxy-2-tetralone | 32940-15-1 |
| 32.18 | Other products | 6,11-Dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid | 55453-87-7 |
| 32.19 | Other products | 6-chlorohexan-2-one | 10226-30-9 |
32.20 | Other products | Benzene sulfonamide | 98-10-2 |
| 32.21 | Other products | Cis trans 1,4-Cyclohexanedicarboxylic acid (TCHA-1) | 1076-97-7 |
| 32.22 | Other products | Etifenin | 63245-28-3 |
| 32.23 | Other products | Formamidine acetate (FEC) | 3473-63-0 |
| 32.24 | Other products | Isonipecotic acid (ISPA) | 498-94-2 |
| 32.25 | Other products | L-Threonine amide HCL | 33209-01-7 |
| 32.26 | Other products | Methyl 1-(4-fluorophenylcarbamoyl) cyclopropane carboxylate | 1345847-71-3 |
| 32.27 | Other products | N- Phenyl Carbazole | 1150-62-5 |
| 32.28 | Other products | N-Benzyl-D-serine. (BDSE-1) | 106910-77-4 |
| 32.29 | Other products | N-BOC-(S)-(-)-2-amino-1-butanol | 150736-72-4 |
32.30 | Other products | N-BOC-2-pyrrolidone | 85909-08-6 |
| 32.31 | Other products | N-BOC-piperidine-4-carboxylic acid | 84358-13-4 |
| 32.32 | Other products | N-BOC-piperidine-4-carboxylic acid | 84358-13-4 |
| 32.33 | Other products | N-Cbz-L-leucine | 2018-66-8 |
| 32.34 | Other products | N-methyl-1-(pyridin-2-yl) methenamine | 21035-59-6 |
| 32.35 | Other products | S-(+)-2 Phenyl Propionic Acid | 7782-24-3 |
| 32.36 | Other products | S-Pyrrolidine-2-carbonitrile HCL | 65732-69-6 |
| 32.37 | Other products | trans 1,4-cyclohexanedicarboxylic acid (TCHA-2) | 619-82-9 |
| 32.38 | Other products | Triglycidyl aminophenol | 5026-74-4 |
| 32.39 | Other products | Z-Threonine-OTBS | 94820-26-5 |
| S.No. | PRODUCT NAME | Category | CAS No. |
|---|---|---|---|
| 1 | a-(meta hydroxy phenyl) ethyldimethyl amine | Rivastigmine Intermediates | 105601-04-5 /HCl 5441-61-2 |
| 2 | S (+)-a meta hydroxy phenyl)ethyl dimethyl amine | Rivastigmine Intermediates | 139306-10-8 |
| 3 | 6-Chloroindolin-2-one | Ziprasidone Intermediates | 56341-37-8 |
| 4 | 6-Chloro-5-(2-chloroethyl)indolin-2-one | Ziprasidone Intermediates | 118289-55-7 |
| 5 | 2-Ethoxyethyl-4-methylbenzenesulfonate | Bilastine Intermediates | 17178-11-9 |
| 6 | 2-Piperidin-4-yl-1H-benzoimidazole | Bilastine Intermediates | 38385-95-4 |
| 7 | 3,4-dihydro-5-hydroxyquinolin-2(1H)-one | Carteolol Intermediates | 30389-33-4 |
| 8 | 5-((oxiran-2-yl)methoxy)-3,4-dihydroquinolin-2(1H)-one | Carteolol Intermediates | 51781-14-7 |
| 9 | 6-Hydroxy-3,4-dihydro-2(1H)-quinolinone | Cilastazole Intermediates | 54197-66-9 |
| 10 | 3-Chloro-1-phenylpropan-1-ol | Dapoxetine HCl Intermediates | 100306-33-0 |
| 11 | Racemic Dapoxetine Oxalate | Dapoxetine HCl Intermediates | |
| 12 | Racemic Dapoxetine Hydrochloride | Dapoxetine HCl Intermediates | 1071929-03-7 |
| 13 | Dapoxetine Base | Dapoxetine HCl Intermediates | 119356-77-3 |
| 14 | 2,2-Diphenyl-2-((R)-pyrrolidin-3-yl)acetonitrile hydrobromide | Darifenacin Intermediates | 194602-27-2 |
| 15 | 3-(S)-(+)-(1-carbamoyl-1,1-diphenylmethyl) pyrrolidine - L-(+)-tartrate | Darifenacin Intermediates | 134002-26-9 |
| 16 | 5-(2-chloroethyl)-2,3-dihydrobenzofuran | Darifenacin Intermediates | 943034-50-2 |
| 17 | 5-(2-bromoethyl)-2,3-dihydrobenzofuran | Darifenacin Intermediates | 127264-14-6 |
| 18 | D Serine Methyl ester Hcl | D- Serine Derivatives | |
| 19 | N-BOC-D-Serine Methyl Ester | D- Serine Derivatives | |
| 20 | L Valine Methyl ester HCL | L Valine Derivatives | |
| 21 | N-CbZ-L-Valine | L Valine Derivatives | |
| 22 | L Valinamide Hcl | L Valine Derivatives | |
| 23 | N BOC L Valine | L Valine Derivatives | |
| 24 | L Prolinamide | L Proline Derivatives | |
| 25 | N-BOC-L-Proline | L Proline Derivatives | |
| 26 | N-BOC-Prolinamide | L Proline Derivatives | |
| 27 | L-Proline Methyl Ester Hcl | L Proline Derivatives | |
| 28 | N-CBZ-L-Proline | L Proline Derivatives | |
| 29 | L Analine Methyl Ester | L Alanine Derivatives | |
| 30 | (S)-3- Chloroalanine Methyl Ester HCl | L Alanine Derivatives | |
| 31 | Boc-D-Serine | Lacosamide Intermediates | 6368-20-3 |
| 32 | Boc-O-Methyl-D-serine | Lacosamide Intermediates | 86123-95-7 |
| 33 | (R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate | Lacosamide Intermediates | 880468-89-3 |
| 34 | (R)-2-amino-N-benzyl-3-methoxypropanamide | Lacosamide Intermediates | 196601-69-1 |
| 35 | N-Cbz-D-Serine | Lacosamide Intermediates | 6081-61-4 |
| 36 | (R)-N-benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide | Lacosamide Intermediates | 219835-31-1 |
| 37 | 2-chloro-N-(2,6-dimethylphenyl)acetamide | Lidocaine Intermediate | 1131-01-7 |
| 38 | (RS)- 6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid | Nebivolol Intermediates | |
| 39 | (S)- 6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid | Nebivolol Intermediates | 129101-36-6 |
| 40 | ® )-6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid | Nebivolol Intermediates | 129101-37-7 |
| 41 | (6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)(piperidin-1-yl)methanone | Nebivolol Intermediates | 878208-57-2 |
| 42 | 6-Fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran (Mixture of Two Diastereomers) | Nebivolol Intermediates | 99199-90-3 |
| 43 | 2-(benzylamino)-1-(6-fluorochroman-2-yl)ethanol | Nebivolol Intermediates | |
| 44 | N-Benzyl Nebivolol Hydrochloride | Nebivolol Intermediates | |
| 45 | Diethyl-2-benzylmalonate | Racecadotril Intermediates | 607-81-8 |
| 46 | 2-Benzylacrylic acid | Racecadotril Intermediates | 5669-19-2 |
| 47 | Glycine benzyl ester P-toluene sulfonic acid | Racecadotril Intermediates | 1738-76-7 |
| 48 | Dimethyl-2-benzylmalonate | Racecadotril Intermediates | 6626-84-2 |
| 49 | 4-(2-(PIPERIDIN-1-YL)ETHOXY)BENZOIC ACID HYDROCHLORIDE | Raloxefine HCl Intermediates | 84449-80-9 |
| 50 | 6-Methylsulfonyloxy-2-[(4-methyl sulfonyloxy) phenyl] benzothiophene | Raloxefine HCl Intermediates | 84449-65-0 |
| 51 | N-(2,6-dimethylphenyl)-2-(piperazin-1-yl)acetamide | Ranolazine Intermediates | 294-61-1 |
| 52 | 2-((2-methoxyphenoxy)methyl)oxirane | Ranolazine Intermediates | 2210-74-4 |
| 53 | (S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine N-Acetyl-L-glutamate | Repaglinide Intermediates | 219921-94-5 |
| 54 | (S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine | Repaglinide Intermediates | 147769-93-5 |
| 55 | (S)-Repaglinide Ethyl Ester | Repaglinide Intermediates | 147770-06-7 |
| 56 | (S)-1,2,3,4-tetrahydro-5-methoxynaphthalen-2-amine Mandelate | Rotigotine Intermediates | |
| 57 | 2-(Thiophen-2-yl)ethyl 4-methylbenzenesulfonate | Rotigotine Intermediates | |
| 58 | (S)-1,2,3,4-tetrahydro-5-methoxy-N-(2-(thiophen-2-yl)ethyl)naphthalen-2-amine hydrochloride | Rotigotine Intermediates | |
| 59 | 2-(2-(2,2,2-trifluoroethoxy)-phenoxy)-ethyl methanesulfonate---- | Silodosin Intermediates | 160969-03-9 |
| 60 | 5-[(2R)-2-Aminopropyl]-1-[3-(Benzoyloxy)propyl]-2,3-dihydro - 1H-indole-7-carbonitrile(2R,3R)-2,3-dihydroxy butanedioate | Silodosin Intermediates | 239463-85-5 |
| 61 | 1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy] ethyl]amino]propyl]-1H-indole-7-carbonitrile | Silodosin Intermediates | 885340-11-4 |
| 62 | 1H-Indole-7-carbonitrile, 2,3-dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)ph enoxy]ethyl]amino]propyl] | Silodosin Intermediates | 885340-13-6 |
| 63 | 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | Sitagliptin Intermediates | 762240-92-6 |
| 64 | 1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)- 4-(2,4,5-trifluorophenyl)butane-1,3-dione /(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo | Sitagliptin Intermediates | |
| 65 | [4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one | Sitagliptin Intermediates | 764667-65-4 |
| 66 | L-Alanine Isopropyl ester hydrochloride | Sofosbuvir Intermediates | 39825-33-7 |
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
